Variational AI, the company behind Enki™, an advanced foundation model for small molecule drug discovery, today announced the completion of its oversubscribed $US5.5 million Seed extension round.
Researchers at the Icahn School of Medicine at Mount Sinai have developed a powerful computational tool, named iDOMO, to ...
A.I. tools from Microsoft and other companies are helping write code, placing software engineers at the forefront of the ...
We recently published a list of the 10 Best Performing Healthcare Stocks So Far in 2025. In this article, we are going to ...
“Partnering with Genesis Therapeutics presents a unique opportunity to leverage their AI technologies to accelerate the ...
A team of US scientists has developed a new foundation model that can sift through genetic code across biology's five ...
Evo 2 now includes information from humans, plants, and other eukaryotic species to expand its capabilities in generative functional genomics.
AI helps scientists decode a cone snail toxin’s targets, paving the way for safer drug development and ecological research.
An interdisciplinary research team from Leipzig University and the Saxon AI center ScaDS.AI has developed a novel approach ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results